Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Darzalex SC (daratumumab )
pCPA File Number:
21266
Negotiation Status:
Concluded without agreement
Indication(s):
Multiple Myeloma
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2020-07-10
Negotiation Process Concluded:
2020-12-16